Potential use of melatonin in sleep and delirium in the critically ill.
about
Sleep disturbance in older ICU patientsEffect of oral melatonin and wearing earplugs and eye masks on nocturnal sleep in healthy subjects in a simulated intensive care unit environment: which might be a more promising strategy for ICU sleep deprivation?Melatonin and melatonin agonists to prevent and treat delirium in critical illness: a systematic review protocolThe effect of chronotherapy on delirium in critical care - a systematic review.The American Geriatrics Society/National Institute on Aging Bedside-to-Bench Conference: Research Agenda on Delirium in Older Adults.Intensive care unit depth of sleep: proof of concept of a simple electroencephalography index in the non-sedatedImpact of oral melatonin on critically ill adult patients with ICU sleep deprivation: study protocol for a randomized controlled trial.Melatonergic drugs in development.Circadian rhythms in anesthesia and critical care medicine: potential importance of circadian disruptionsPharmacological interventions for delirium in intensive care patients: a protocol for an overview of reviewsHealth implications of disrupted circadian rhythms and the potential for daylight as therapy.Editorial: Health Impact and Management of a Disrupted Circadian Rhythm and Sleep in Critical IllnessesEnteral vs. intravenous ICU sedation management: study protocol for a randomized controlled trialProphylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial.Can intensive care unit delirium be prevented and reduced? Lessons learned and future directionsThe pharmacologic management of delirium in children and adolescents.Do antipsychotics prevent postoperative delirium? A systematic review and meta-analysis.Positive and negative effects of mechanical ventilation on sleep in the ICU: a review with clinical recommendations.Pharmacologic and nonpharmacologic approaches to the prevention and management of delirium.Sleep Disruption at Home As an Independent Risk Factor for Postoperative Delirium.Melatonin Receptor Agonists for Delirium Prevention.Pharmacokinetics of a novel dosing regimen of oral melatonin in critically ill patients.Development of core outcome sets for effectiveness trials of interventions to prevent and/or treat delirium (Del-COrS): study protocol.Melatonin Pharmacological Blood Levels Increase Total Antioxidant Capacity in Critically Ill Patients.Effect of melatonin on duration of delirium in organophosphorus compound poisoning patients: A double-blind randomised placebo controlled trial.Melatonin - marvel in the making?Pediatric Delirium: Evaluation, Management, and Special Considerations.Seven unconfirmed ideas to improve future ICU practice.Investigating the application of motion accelerometers as a sleep monitoring technique and the clinical burden of the intensive care environment on sleep quality: study protocol for a prospective observational study in Australia.Delirium in the Cardiac Intensive Care Unit.The Period 2 Enhancer Nobiletin as Novel Therapy in Murine Models of Circadian Disruption Resembling Delirium.
P2860
Q27028061-10416E0D-9500-4F06-8149-B584C5868E76Q28390136-B598D7A4-79C6-428A-9A60-D0D768813E79Q28818952-05127524-912A-4E22-BE7D-5129B9271510Q30402005-0C5DCCE3-B818-4121-9FCA-7D8B93DF9528Q33610107-F07143A8-FA6F-4A53-B93A-D7CA3BAAFA5EQ33753018-4316542E-0012-41E7-95B3-9DDC6B90C005Q34151016-809C1147-E9DE-49B3-AA0A-3E8A33794154Q34440574-965DA78A-0C8F-44D8-8301-8A20A1F96EF4Q35771444-60BB9ABE-F73D-4DBC-A74C-BFE33D9AAF16Q36214472-F5EADAF5-3186-4733-9D84-48FE6206F761Q36248106-A861A6A0-CC72-425A-9D18-60D9F0D66392Q36355472-FB6B4793-1C34-4E95-923D-0D04A99BAF46Q36836619-BB31A565-9527-4586-AC32-A0AA9702F933Q37569363-E22EF81A-F6D4-4830-AA86-D250F8E75441Q37651713-A9E3C33C-3ED3-4EEE-90CE-FEBC2A3F5D89Q38217727-4519F805-4FB2-402D-BF6D-62CECB06CF39Q38339691-2559E071-690D-40AE-95E0-2F2254D04B88Q38694083-D0AE0FB7-3C51-43F6-B4BE-33FFFC92A2BDQ38760118-598F25C6-CFF2-4C51-9866-29DAB71FE2D1Q38901353-185F2E46-FDD2-4662-A7CB-03F3F4E4EC33Q38931468-0433B035-5790-4505-8DAF-0A97FB3B1F27Q40560062-68977C6E-88CC-484C-9EE1-1089F647E2D9Q42172775-26351089-4DFB-4CAA-8FA7-D14A15CBA335Q42289972-DA18EEAC-7F8B-4745-954D-8BC202DAA4B7Q42362945-5B217A79-FDBC-49D2-B775-3D73E66E1D01Q42383017-31859D77-17A5-47FA-B3AA-12B177895972Q46108946-11A3B56C-FC45-4D8E-B546-A0AB1CBA7C68Q47136454-9C39D881-2834-4D56-B255-0507AAEC3E55Q47642353-353CA7A6-B077-466E-BA76-BD12E8F8C547Q49913763-A3794CC9-AD2A-4ED4-9D62-14B38F9E2FC0Q50533803-6F663067-5683-4803-B428-2C277ADE9F8F
P2860
Potential use of melatonin in sleep and delirium in the critically ill.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Potential use of melatonin in sleep and delirium in the critically ill.
@en
Potential use of melatonin in sleep and delirium in the critically ill.
@nl
type
label
Potential use of melatonin in sleep and delirium in the critically ill.
@en
Potential use of melatonin in sleep and delirium in the critically ill.
@nl
prefLabel
Potential use of melatonin in sleep and delirium in the critically ill.
@en
Potential use of melatonin in sleep and delirium in the critically ill.
@nl
P356
P1476
Potential use of melatonin in sleep and delirium in the critically ill
@en
P2093
J Bellapart
P304
P356
10.1093/BJA/AES035
P407
P50
P577
2012-04-01T00:00:00Z